Rating History
Dissemination Date Long-Term Rating Short-Term Rating Outlook Action Rating Watch
12-May-25 BBB A2 Stable Maintain -
23-May-24 BBB A2 Stable Maintain -
23-May-23 BBB A2 Stable Maintain -
23-May-22 BBB A2 Stable Initial -
About the Entity

Ziauddin University (“the University”) was established through ACT VI of 1995 (Ziauddin Medical University ACT) by the Provincial Assembly of the Government of Sindh. The University is a non-profit private institution which provides higher education services. It is accredited and recognized by the Higher Education Commission of Pakistan (HEC). The University has its branch campuses in Karachi and Sukkur. The Board of Governors (BoG) includes representatives from Dr. Ziauddin Hospitals Trust, Government and Regulatory Bodies. Mr. Asim Hussain serves as Chairman of the BoG and Chancellor of the University.

Rating Rationale

Ziauddin University ("The University") is a non-profit organization established in 1995. The University has progressively broadened its academic portfolio beyond its original emphasis on medical education to encompass disciplines such as Management Sciences and Information Technology. This strategic expansion has positioned it as one of Pakistan’s premier institutions in the realm of higher education. The University boasts a significant footprint in the academic sector, offering a comprehensive suite of programs, and is characterized by a robust enrollment process and a dedicated faculty. This progressive approach includes strategic geographic expansion, with multiple campuses in Karachi and a recent addition in Sukkur. The Sukkur campus offers Doctor of Pharmacy and Physiotherapy programs, with plans to establish a teaching hospital to further strengthen the University’s healthcare education. Ziauddin Medical College, a flagship faculty of the University, remains a cornerstone of its success, recognized for academic excellence and superior clinical training. In addition to enhancing the University's educational reputation, the College generates over 45% of its total revenue, underscoring its strategic importance. The University has also achieved significant progress in nursing education, notably offering a PhD in Nursing, one of the few programs of its kind in Pakistan. This reflects a forward-thinking approach to meeting the rising demand for skilled healthcare professionals both locally and internationally.
Further bolstering its reputation in healthcare, Ziauddin University established a Clinical Trial Unit in 2023, a facility designed to advance the University’s research capabilities. This unit has not only become a hub for clinical research but has also evolved into a revenue-generating facility, further enhancing the University’s research monetization potential. With a focus on clinical trials, the University is well-positioned to contribute to the global healthcare community’s ongoing search for new treatments and therapies. Ziauddin University has consistently sustained healthy margins. The leadership team reflects a positive perspective on the University’s potential to cultivate a financial surplus, vital for underpinning future growth endeavors. The University’s creditworthiness is reinforced by a stable financial profile, marked by a low-leveraged capital structure and strong coverage ratios. The working capital cycle is efficiently managed. Moreover, the presence of renowned educationists on the Board of Governors and Board of Trustees ensures a stable governance framework adding strength to the University's profile. The University has an array of national accreditations and international linkages.

Key Rating Drivers

The ratings are dependent upon the management’s ability to sustain margins while remaining self-sufficient and in surplus for expansionary measures. Prudent management of the working capital, and maintaining sufficient cash flows, and coverages remain imperative for the ratings. Any significant deterioration in coverages and/or margins will adversely impact the ratings.

Profile
Legal Structure

Ziauddin University (‘the University’) was established through ACT VI of 1995 (Ziauddin Medical University ACT) by the Provincial Assembly of the Government of Sindh. The University is a non-profit private institution accredited and recognized by the Higher Education Commission of Pakistan.


Background

The Ziauddin Group began as a small maternity home in Nazimabad, founded by Dr. Aijaz Fatima and Dr. Tajammul Hussain, in honour of Sir Dr. Ziauddin Ahmad(former Vice Chancellor of Ali Garh University). Over time, it evolved into a major healthcare and education network, comprising three tertiary hospitals, community health projects, a TV and radio channel, and a university. The academic journey started in 1986 with the School of Nursing. In 1994, the Dr. Ziauddin Postgraduate Institute of Medical Sciences was established. Ziauddin Medical University received its charter as Ziauddin University in 2005. Originally focused on medical sciences, it has since grown into a multidisciplinary institution. Today, Ziauddin University offers degrees in medicine, law, business, media, veterinary sciences, and more.


Operations

Ziauddin University operates branch campuses in Karachi and Sukkur, offering more than 90 undergraduate and postgraduate programs across a wide array of disciplines, including medical and health sciences, social sciences, technology and management, and liberal arts. The University comprises 9 faculties and 24 colleges/departments, with a student body exceeding 6,500. A team of 625 faculty members supports the academic mission, ensuring quality education across all departments. Ziauddin Medical College is associated with Ziauddin Hospital Trust which has a capacity of 845 beds. The main campuses in Karachi, developed on trust-owned land, host over 4,000 students. The Sukkur campus, currently partially operational, offers degree programs in Doctor of Pharmacy and Doctor of Physiotherapy, and features purpose-built academic buildings, classrooms, cafeterias, auditoriums, and student facilities. The University library houses extensive academic resources for students and faculty. Additionally, Ziauddin University has a dedicated Research Department and a Clinical Trial Unit actively engaged in cancer medication research and isotope development.


Ownership
Ownership Structure

The University being non-profit educational institute chartered by the Government, is a corporate body having perpetual succession.


Stability

The structure is seen as stable as the third generation of the founding family has been inducted in the operations of the Trust and the University.


Business Acumen

The members of the Trust are highly committed individuals with extensive experience and a deep understanding of both domestic and international trends in the education sector. Their strategic insight plays a crucial role in guiding the University's direction. This experienced leadership enhances institutional strength and long-term sustainability. Their dedication supports continued growth and academic excellence.


Financial Strength

Since the University operates alongside the Trust, the financial standing of the Trust and the personal wealth of the members provide comfort in the welfare of the University.


Governance
Board Structure

The Board of Governors (BoG), comprising 11 members, serves as the highest governing body of the University, responsible for formulating policies and strategic plans related to academic and administrative affairs. The BoG also oversees initiatives aimed at enhancing the efficiency and effectiveness of the University's operations. The composition and roles of the Board members are clearly defined in the University’s founding Ordinance.


Members’ Profile

The members of the Board of Governors (BoG) bring diverse educational backgrounds and extensive professional experience, offering seasoned guidance to the University’s leadership. The Chairman of the BoG, Dr. Asim Hussain, also serves as Chairman of the Trust. A distinguished surgeon, he possesses over three decades of experience in research and teaching. Dr. Nida Hussain, the Pro-Chancellor of Ziauddin University, leads Ziauddin Schools and Colleges and has over 12 years of experience in internal medicine; she also serves as a Consultant General Physician at Ziauddin Hospital. The BoG includes eminent individuals such as a member of the Senate of Pakistan, the President of the Karachi Chamber of Commerce and Industry, a former government bureaucrat, and a former judge of the Sindh High Court—bringing multifaceted perspectives to university governance.


Board Effectiveness

The sufficient experience of majority of the members on the BoG provides useful insight into the education sector. The BoG meets twice a year and is assisted by the Academic Council and Audit Committee.


Financial Transparency

The External Auditors of the Company Grant Thornton Anjum Rahman Chartered Accountants a QCR-rated firm expressed an unqualified opinion of Financial Statements for the period ended Jun’24. The Firm is Category ‘A’ on SBP panel.


Management
Organizational Structure

The University operates primarily through its administration, treasury, academics, internal audit, research, and compliance functions. The Pro-Chancellor oversees all departments and reports directly to the Chancellor, who in turn reports to the Board of Governors (BoG). The Head of Internal Audit reports directly to the BoG's Audit Committee, ensuring independent oversight and transparency.


Management Team

The Chancellor, Dr. Asim Hussain, is a distinguished surgeon with over three decades of experience in research and teaching. The Pro-Chancellor, Dr. Nida Hussain, holds a medical degree and brings 16 years of experience in medicine and teaching. Additionally, Professor Dr. Abbas Zafar currently serves as the Acting Vice-Chancellor of the University, contributing over 20 years of dedicated service to the institution.


Effectiveness

The long-standing association of the senior management with the University has ensured continuity in policy development and reinforced the management structure. Their experience has been instrumental in maintaining stability and guiding the institution's growth. This consistency fosters a strong foundation for future progress.


MIS

The University has deployed proper technology infrastructure to manage the information related to its main activities. The University uses Oracle as its ERP software. Reports are regularly shared with the management of the University.


Control Environment

The University maintains a clear segregation of duties, which strengthens its control environment and ensures efficient operations. Each department’s responsibilities are well-defined, promoting accountability and transparency. Additionally, the in-house Internal Audit Department plays a crucial role in monitoring the implementation of policies and procedures. This oversight ensures compliance and enhances operational effectiveness. The presence of this department supports continuous improvement and adherence to best practices.


Business Risk
Industry Dynamics

Pakistan's education sector contributed -2.3% to GDP in FY24, with tertiary education seeing steady growth. University enrolments, led by rising demand from the 15-29 age group, which forms -26.6% of the population. Sector revenues grew -21.3% YoY, supported by increased enrolments and higher tuition fees. Operating and net margins improved to -14.8% and -16.4%, respectively, reflecting efficient cost management. Despite low public education spending (-0.1% of GDP), private sector participation remains strong. The sector's borrowing structure is moderately diversified, with 33.6% in construction financing. With a growing youth base and digital advancements, the outlook for higher education remains stable and expansionary.


Relative Position

The University commands a strong market position in Sindh, ranking among the top five universities based on programs offered, student enrolment, and faculty strength. Its Medical College is recognized as one of the top medical institutions in Pakistan. This reflects the University's commitment to academic excellence and sectoral leadership. Its diverse offerings and strong reputation continue to attract students across disciplines.


Revenues

The University demonstrated strong financial performance in FY24, with gross revenue rising to PKR 2,871mln from PKR 2,478mln in FY23, reflecting a robust 15.9% year-over-year growth. This increase was primarily driven by tuition fees, supported by secondary income from fines and clinical trials. The College of Medicine remains the dominant revenue contributor, generating approximately 45% of total income. The growth reflects the University’s effective pricing strategy and strategic program expansion. Despite sectoral challenges, the University maintained revenue momentum, showcasing its resilience. This performance underscores the strength of its financial framework and adaptability in a competitive higher education environment.


Margins

In FY24, the gross margin declined to 17.3%, down from 19.5% in FY23, primarily due to increased Salaries and wages cost which continues to represent the University’s largest cost component which was PKR 1,041mln in FY23 compared to increase of PKR 1,281mln in FY24. Similarly, the operating margin moderated to 2.8%, compared to 4.0% in the previous year, reflecting the impact of rising expenditures. Despite revenue growth, profitability at the bottom line also softened. The University reported a net profit of PKR 64 mln in FY24, compared to PKR 116 mln in FY23, resulting in a contraction in the net margin to 2.2%, from 7.2% a year earlier, because of the rise in finance cost. The trend underscores the need for greater cost efficiency as the University continues to expand its academic and infrastructural footprint.


Sustainability

The University continues its growth trajectory with the successful completion of its Sukkur campus, aligned with its strategic expansion objectives. Initially planned to be financed through a balanced mix of equity and debt, the project has now reached full operational status. Academic activity has commenced with the launch of Doctor of Pharmacy and Doctor of Physiotherapy programs. This development marks a significant milestone in extending the University’s regional footprint. It reflects the institution’s commitment to accessible, quality education beyond its primary campus. The Sukkur campus stands as a testament to its forward-looking vision and execution capabilities.


Financial Risk
Working capital

The University’s working capital requirements are primarily driven by trade receivables and trade payables, as its operations do not involve significant inventory holdings. Employee salaries make up the majority of trade payables, while student fee receivables account for the bulk of trade receivables. In FY24, the University reported net working capital days of 42, a significant improvement from 99 days in FY23. This improvement is largely due to a reduction in receivable days, which dropped to 91 from 126 in the prior year, coupled with an increase in payable days to 49 (FY23: 27 days). The enhanced working capital cycle reflects greater efficiency in managing collections and payables.


Coverages

The University’s FCFO’s increased to PKR 665 mln in FY24 (FY23: PKR 430 mln), driven by reduced costs and enhanced operational efficiency. However, finance costs rose to PKR 264 mln (FY23: PKR 213 mln), resulting in a modest improvement in the interest coverage ratio to 2.6x (FY23: 2.2x). The debt coverage ratio also improved to 1.3x (FY23: 1.1x), reflecting  a slight enhancement in the University’s ability to meet debt obligations. Despite these improvements, financial flexibility remains limited.


Capitalization

The University maintains a low leveraged capital structure, with a leverage ratio of 24.9% in FY24, reflecting a prudent borrowing strategy. As of FY24, the University total borrowings consist of both short-term and long-term debt, primarily utilized for working capital management and expansion purposes. Repayments on the long-term loan are being made progressively over time. Total borrowings slightly decreased to PKR 1,073mln in FY24, compared to PKR 1,306mln in FY23. The University capital structure remains well-balanced, with a solid equity base of PKR 3.2bln in FY24. This growth in equity strengthens the University financial position, providing a buffer against financial risks and reinforcing its capacity to service debt. Going forward, the leverage ratio is expected to remain stable, as the University has no plans for additional long-term debt borrowing.


 
 

May-25

www.pacra.com


Jun-24
12M
Jun-23
12M
Jun-22
12M
A. BALANCE SHEET
1. Non-Current Assets 3,847 3,483 2,785
2. Investments 738 754 496
3. Related Party Exposure 614 610 473
4. Current Assets 1,491 1,378 1,760
a. Inventories 0 0 0
b. Trade Receivables 606 822 883
5. Total Assets 6,689 6,224 5,514
6. Current Liabilities 1,953 1,533 1,145
a. Trade Payables 503 265 98
7. Borrowings 1,073 1,306 1,365
8. Related Party Exposure 387 158 0
9. Non-Current Liabilities 30 46 0
10. Net Assets 3,246 3,181 3,004
11. Shareholders' Equity 3,246 3,181 3,004
B. INCOME STATEMENT
1. Sales 2,871 2,478 1,961
a. Cost of Good Sold (2,374) (1,996) (1,612)
2. Gross Profit 497 482 349
a. Operating Expenses (416) (384) (340)
3. Operating Profit 82 98 9
a. Non Operating Income or (Expense) 246 292 215
4. Profit or (Loss) before Interest and Tax 328 391 225
a. Total Finance Cost (264) (213) (109)
b. Taxation 0 0 0
6. Net Income Or (Loss) 64 177 116
C. CASH FLOW STATEMENT
a. Free Cash Flows from Operations (FCFO) 665 430 391
b. Net Cash from Operating Activities before Working Capital Changes 403 273 388
c. Changes in Working Capital 721 474 (194)
1. Net Cash provided by Operating Activities 1,124 747 193
2. Net Cash (Used in) or Available From Investing Activities (719) (1,048) (1,079)
3. Net Cash (Used in) or Available From Financing Activities (132) (128) 972
4. Net Cash generated or (Used) during the period 273 (428) 86
D. RATIO ANALYSIS
1. Performance
a. Sales Growth (for the period) 15.9% 26.4% 10.3%
b. Gross Profit Margin 17.3% 19.5% 17.8%
c. Net Profit Margin 2.2% 7.2% 5.9%
d. Cash Conversion Efficiency (FCFO adjusted for Working Capital/Sales) 48.3% 36.5% 10.0%
e. Return on Equity [ Net Profit Margin * Asset Turnover * (Total Assets/Shareholders' Equity )] 2.0% 5.7% 3.9%
2. Working Capital Management
a. Gross Working Capital (Average Days) 91 126 145
b. Net Working Capital (Average Days) 42 99 132
c. Current Ratio (Current Assets / Current Liabilities) 0.8 0.9 1.5
3. Coverages
a. EBITDA / Finance Cost 2.6 2.2 13.4
b. FCFO / Finance Cost+CMLTB+Excess STB 1.3 1.1 1.1
c. Debt Payback (Total Borrowings+Excess STB) / (FCFO-Finance Cost) 2.0 4.0 3.0
4. Capital Structure
a. Total Borrowings / (Total Borrowings+Shareholders' Equity) 24.9% 29.1% 31.2%
b. Interest or Markup Payable (Days) 79.8 98.6 9.2
c. Entity Average Borrowing Rate 20.7% 15.2% 3.5%

May-25

www.pacra.com

May-25

www.pacra.com

  1. Rating Team Statements
    1. Rating is just an opinion about the creditworthiness of the entity and does not constitute a recommendation to buy, hold, or sell any security of the entity rated or to buy, hold, or sell the security rated, as the case may be. (Chapter III; 14-3-(x))
    2. Conflict of Interest
      1. The Rating Team or any of their family members have no interest in this rating (Chapter III; 12-2-(j))
      2. PACRA, the analysts involved in the rating process, and members of its rating committee and their family members do not have any conflict of interest relating to the rating done by them (Chapter III; 12-2-(e) & (k))
      3. The analyst is not a substantial shareholder of the customer being rated by PACRA [Annexure F; d-(ii)]
      4. Explanation: for the purpose of the above clause, the term "family members" shall include only those family members who are dependent on the analyst and members of the rating committee.
  2. Restrictions
    1. No director, officer, or employee of PACRA communicates the information acquired by him for use for rating purposes to any other person, except where required under law to do so. (Chapter III; 10-(5))
    2. PACRA does not disclose or discuss with outside parties or make improper use of the non-public information which has come to its knowledge during a business relationship with the customer. (Chapter III; 10-7-(d))
    3. PACRA does not make proposals or recommendations regarding the activities of rated entities that could impact a credit rating of the entity subject to rating. (Chapter III; 10-7-(k))
  3. Conduct of Business
    1. PACRA fulfills its obligations in a fair, efficient, transparent, and ethical manner and renders high standards of services in performing its functions and obligations. (Chapter III; 11-A-(a))
    2. PACRA uses due care in the preparation of this Rating Report. Our information has been obtained from sources we consider to be reliable, but its accuracy or completeness is not guaranteed. PACRA does not, in every instance, independently verify or validate information received in the rating process or in preparing this Rating Report. (Clause 11-(A)(p))
    3. PACRA prohibits its employees and analysts from soliciting money, gifts, or favors from anyone with whom PACRA conducts business. (Chapter III; 11-A-(q))
    4. PACRA ensures before the commencement of the rating process that an analyst or employee has not had a recent employment or other significant business or personal relationship with the rated entity that may cause or may be perceived as causing a conflict of interest. (Chapter III; 11-A-(r))
    5. PACRA maintains the principle of integrity in seeking rating business. (Chapter III; 11-A-(u))
    6. PACRA promptly investigates in the event of misconduct or a breach of the policies, procedures, and controls, and takes appropriate steps to rectify any weaknesses to prevent any recurrence, along with suitable punitive action against the responsible employee(s). (Chapter III; 11-B-(m))
  4. Independence & Conflict of Interest
    1. PACRA receives compensation from the entity being rated or any third party for the rating services it offers. The receipt of this compensation has no influence on PACRA’s opinions or other analytical processes. In all instances, PACRA is committed to preserving the objectivity, integrity, and independence of its ratings. Our relationship is governed by two distinct mandates: i) rating mandate - signed with the entity being rated or issuer of the debt instrument, and ii) fee mandate - signed with the payer, which can be different from the entity.
    2. PACRA does not provide consultancy/advisory services or other services to any of its customers or their associated companies and associated undertakings that are being rated or have been rated by it during the preceding three years, unless it has an adequate mechanism in place ensuring that the provision of such services does not lead to a conflict of interest situation with its rating activities. (Chapter III; 12-2-(d))
    3. PACRA discloses that no shareholder directly or indirectly holding 10% or more of the share capital of PACRA also holds directly or indirectly 10% or more of the share capital of the entity which is subject to rating or the entity which issued the instrument subject to rating by PACRA. (Chapter III; 12-2-(f))
    4. PACRA ensures that the rating assigned to an entity or instrument is not affected by the existence of a business relationship between PACRA and the entity or any other party, or the non-existence of such a relationship. (Chapter III; 12-2-(i))
    5. PACRA ensures that the analysts or any of their family members shall not buy, sell, or engage in any transaction in any security which falls in the analyst’s area of primary analytical responsibility. This clause, however, does not apply to investments in securities through collective investment schemes. (Chapter III; 12-2-(l))
    6. PACRA has established policies and procedures governing investments and trading in securities by its employees and for monitoring the same to prevent insider trading, market manipulation, or any other market abuse. (Chapter III; 11-B-(g))
  5. Monitoring and Review
    1. PACRA monitors all the outstanding ratings continuously, and any potential change therein due to any event associated with the issuer, the security arrangement, the industry, etc., is disseminated to the market immediately and in an effective manner after appropriate consultation with the entity/issuer. (Chapter III; 17-(a))
    2. PACRA reviews all the outstanding ratings periodically on an annual basis. Provided that public dissemination of annual review and in an instance of change in rating will be made. (Chapter III; 17-(b))
    3. PACRA initiates an immediate review of the outstanding rating upon becoming aware of any information that may reasonably be expected to result in downgrading of the rating. (Chapter III; 17-(c))
    4. PACRA engages with the issuer and the debt securities trustee to remain updated on all information pertaining to the rating of the entity/instrument. (Chapter III; 17-(d))
  6. Probability of Default
    1. PACRA’s Rating Scale reflects the expectation of credit risk. The highest rating has the lowest relative likelihood of default (i.e., probability). PACRA’s transition studies capture the historical performance behavior of a specific rating notch. Transition behavior of the assigned rating can be obtained from PACRA’s Transition Study available at our website. (www.pacra.com) However, the actual transition of rating may not follow the pattern observed in the past. (Chapter III; 14-3(f)(vii))
  7. Proprietary Information
    1. All information contained herein is considered proprietary by PACRA. Hence, none of the information in this document can be copied or otherwise reproduced, stored, or disseminated in whole or in part in any form or by any means whatsoever by any person without PACRA’s prior written consent.

May-25

www.pacra.com